Osakidetza acquires IBA Proteus One proton therapy system in €86.3M project

Osakidetza, the Basque Government's health service, is acquiring a Proteus One proton therapy system manufactured by IBA in a project involving an €86.3 million investment. The system is in installation and commissioning, with first patient treatments targeted for January 2027.

Detected & updated continuously · Source: Nebula

Story subjects

IBAOsakidetza

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula